Device Master File Submitted to FDA

OncoSec submits the Device Master File (DMF) for its patented OncoSec Medical System (OMS) to the U.S. Food and Drug Administration (FDA).

The device consists of a generator and hand-held applicator designed to deliver DNA-based cytokines and chemotherapeutic agents for the treatment of solid tumor cancers. Numerous Phase I through Phase IV clinical trials have demonstrated the safe effective use of the device in optimizing cellular uptake of DNA based cytokines or chemotherapeutic agents resulting in improved therapeutic benefits for the patient.